- Home
- THAR vs YCBD Comparison
THAR vs YCBD Comparison
Compare THAR & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- YCBD
- Stock Information
- Founded
- THAR 2017
- YCBD 2015
- Country
- THAR United States
- YCBD United States
- Employees
- THAR N/A
- YCBD N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- THAR Health Care
- YCBD Health Care
- Exchange
- THAR Nasdaq
- YCBD Nasdaq
- Market Cap
- THAR 4.0M
- YCBD 3.2M
- IPO Year
- THAR 2022
- YCBD N/A
- Fundamental
- Price
- THAR $1.25
- YCBD $0.27
- Analyst Decision
- THAR Strong Buy
- YCBD
- Analyst Count
- THAR 1
- YCBD 0
- Target Price
- THAR $17.00
- YCBD N/A
- AVG Volume (30 Days)
- THAR 135.2K
- YCBD 965.3K
- Earning Date
- THAR 05-08-2025
- YCBD 05-14-2025
- Dividend Yield
- THAR N/A
- YCBD N/A
- EPS Growth
- THAR N/A
- YCBD N/A
- EPS
- THAR N/A
- YCBD N/A
- Revenue
- THAR N/A
- YCBD $19,220,238.00
- Revenue This Year
- THAR N/A
- YCBD $13.00
- Revenue Next Year
- THAR N/A
- YCBD $10.00
- P/E Ratio
- THAR N/A
- YCBD N/A
- Revenue Growth
- THAR N/A
- YCBD N/A
- 52 Week Low
- THAR $1.20
- YCBD $0.21
- 52 Week High
- THAR $7.13
- YCBD $1.25
- Technical
- Relative Strength Index (RSI)
- THAR 32.14
- YCBD 38.62
- Support Level
- THAR $1.20
- YCBD $0.21
- Resistance Level
- THAR $1.47
- YCBD $0.42
- Average True Range (ATR)
- THAR 0.15
- YCBD 0.04
- MACD
- THAR -0.01
- YCBD 0.01
- Stochastic Oscillator
- THAR 2.04
- YCBD 14.33
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.